Pharma Corner | Technmarathi

का घ्यावी Paracetamol Tablets? पारासेटामोल व त्याचे 2 उपयोग

Paracetamol Tablets मित्रांनो आपण नेहमी दैनंदिन जीवनात बघितलं तर आपल्या प्रत्येकाच्या घरात गोळ्या औषधांचा एक बॉक्स असतो. त्या मध्ये वारंवार वापर होणारी औषधे असतात त्यातील एक औषध म्हणजे Paracetamol Tablets. आज भारतीय मार्केट मध्ये पॅरासेटमॉल चे खूप ब्रॅंडस आहे त्यापैके काही ब्रॅंड व त्याची उत्पादन करणाऱ्या कोमपण्या खालील प्रमाणे आहे ब्रॅंड चे नाव उत्पादन करणारे कंपनी Calpol Glaxo SmithKline Pharmaceuticals Ltd Dolo Micro Labs Ltd Sumo L Alkem Laboratories Ltd Kabimol Fresenius Kabi India Pvt Ltd Fepanil Veritaz Healthcare Ltd …

1 Fake Liver Medicine DEFITELIO defibrotide sodium in India: WHO Alert!!

by technmarathi.in

In a startling revelation, the World Health Organization (WHO) issued a grave warning on Monday concerning the detection of a counterfeit batch of the liver drug DEFITELIO defibrotide sodium in India and Turkiye. This alert came as a shockwave, as the “falsified product” was first identified in India in April 2023, followed by its emergence in Turkiye just two months later, in July. The fake drug, as per WHO, had infiltrated the market outside the realms of regulated and authorized …

Grasping USFDA 483 Observations for Compliance Success

by technmarathi.in

USFDA 483 observations hold significant importance in the arena of regulatory compliance. This comprehensive guide will unfold the complexities of these observations, covering everything from their meaning to dealing with them effectively. If you’re in the pharmaceutical, biotechnology, or medical device industry, understanding USFDA 483 observations is crucial to uphold regulatory compliance and product quality. Introduction In the ever-changing landscape of the pharmaceutical and medical sectors, adhering to regulatory compliance is a cornerstone for ensuring product safety and effectiveness. The …

Pharmaceutical guidance revised? what’s are 3 changes & why?

by technmarathi.in

Pharmaceutical Guidance updation in india by The Indian government has issued new guidelines for pharmaceutical companies, aimed at improving the quality of medicines produced. These changes come as India strives to position itself as a global leader in generic medicine manufacturing. This article explores the major updates, reasons for the improvements, the significance of uniform standards, and the timeline for implementation. Major Updates and Reasons for New Pharmaceutical guidance The revised Pharmaceutical Guidance focus on enhancing quality control measures, documentation, …

Unveiling Quality Lapses in Intas Pharmaceuticals USFDA 483

by technmarathi.in

Introduction: Discover the comprehensive analysis of the recent FDA inspection at Intas Pharmaceuticals Limited, shedding light on crucial deviations from the current good manufacturing practice (CGMP) guidelines. This scrutiny delves into the intricate details of the pharmaceutical enterprise’s manufacturing facility, highlighting the identified transgressions and their implications. Key Highlights: Thorough FDA inspection between November 22 and December 02, 2022, assessed CGMP compliance in Intas Pharmaceuticals’ India-based drug manufacturing establishment. Quality Control (QC) lapses in ensuring drug product adherence to identity, …